Drug & Supplement Interactions

Evodia + Larotrectinib

Brand names of Larotrectinib

  • Vitrakvi
  • VitrakviI

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Theoretically, CYP3A4 inhibitors might increase the levels and clinical effects of evodia. Of the 2 interaction records for this pair, the most serious is rated moderate.

This also applies to Vitrakvi and VitrakviI, brand names of larotrectinib.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

Larotrectinib may raise evodia levels, possibly making its effects and side effects stronger or harder to predict, based so far on lab and animal research. Since evodia is poorly studied, talk with your oncology team or pharmacist before combining it with this cancer medicine.

Read his full note1-minute read
Moderate
Possible
2
D

Ask a Question About This Combination

Ask in your own words about taking Evodia with Larotrectinib. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Evodia and Larotrectinib Interaction

2 interaction records apply to these two. Each one is explained separately below.

Why Are There 2 Interaction Records?

We file Evodia’s interactions under single medicines and under categories of medicines that share an effect. Larotrectinib is named in, or belongs to, 2 of them, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 2

Evodia With Cytochrome P450 3A4 (CYP3A4) Inhibitors

Why this applies to Larotrectinib

  1. The SupplementEvodia
  2. Interacts With the CategoryCytochrome P450 3A4 (CYP3A4) Inhibitors
  3. Which IncludesLarotrectinib

We sort drugs into categories. Larotrectinib is in our Cytochrome P450 3A4 (CYP3A4) Inhibitors category, and Evodia interacts with every drug in it, so this interaction applies to Larotrectinib.

Interaction Details Explained

Theoretically, CYP3A4 inhibitors might increase the levels and clinical effects of evodia.
Animal research shows that concomitant administration of ketoconazole, a known CYP3A4 inhibitor, with the alkaloid constituents of evodia significantly increases the area under the curve (AUC), maximum concentration (Cmax), and half-life of these constituents.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Evodia + Cytochrome P450 3A4 (CYP3A4) Inhibitors Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's a twist worth understanding: this interaction is actually about how larotrectinib could affect evodia, not the other way around. Larotrectinib has some ability to block the liver enzyme CYP3A4, which is the same enzyme that helps break down evodia's active compounds. In animal studies, when a CYP3A4 blocker was given alongside evodia, the evodia compounds built up to higher levels and lingered longer in the body.

So in theory, taking them together might raise evodia levels and make its effects (and any side effects) stronger or harder to predict. Keep in mind this is based only on lab and animal research, so it's not proven in people. Still, since evodia isn't well studied and you're on a serious cancer medicine, please run this by your oncology team or pharmacist before combining them.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Zhang W, Guo J, Wang D, et al. Effect of CYP3A inducer/inhibitor on pharmacokinetics of five alkaloids in Evodiae Fructus. Chem Biol Interact 2020;327:109146. PubMed
Moderate Interaction 2 of 2

Evodia With Cytochrome P450 3A4 (CYP3A4) Substrates

Larotrectinib is also in our Cytochrome P450 3A4 (CYP3A4) Substrates category.

Interaction Details Explained

Theoretically, evodia might increase the levels and clinical effects of CYP3A4 substrates.
In vitro research shows that evodia extract inhibits hepatic CYP3A4. This effect has not been reported in humans.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Evodia + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Your body relies on a liver enzyme called CYP3A4 to clear larotrectinib (Vitrakvi). In test tube studies, evodia appears to slow that same enzyme down. If that were to happen in people, larotrectinib could build up to higher levels than intended, which may mean more of its typical side effects, things like dizziness, fatigue, nausea, constipation, or changes in your liver blood tests.

The important caveat: this concern comes only from lab research, not from real patients, so it's theoretical at this point. Still, larotrectinib is a cancer therapy where steady, predictable levels matter. I'd hold off on combining them and check with your oncologist or pharmacist first before adding evodia.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Iwata H, Tezuka Y, Kadota S, et al. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract. Drug Metab Pharmacokinet 2005;20:34-45. PubMed
Know someone taking this combination? Share

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Evodia Also Interacts With Other Medications

Besides Larotrectinib, Evodia has 950 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Evodia

Covers the 2,830 medications we’ve checked against Evodia. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Larotrectinib

Take other supplements too? 148 supplements have a documented interaction with Larotrectinib, each explained on its page.

By severity: 3 major, 103 moderate and 42 minor.

The Most Serious There Right Now:

Open the Larotrectinib interaction pageEvery supplement checked against Larotrectinib, ranked by severity
One More Smart Check

Taking Evodia as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Evodia. We have broken down 182 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Larotrectinib:

Get to Know Each One

About Evodia and Larotrectinib

Supplement

About Evodia

Evodia is a fruit used in traditional Chinese medicine, most often for digestive complaints, headaches, and menstrual pain. Human evidence for these uses is very limited, and it is mostly studied in laboratory and animal research. Talk with a pharmacist or doctor before using it, and avoid it during pregnancy and breastfeeding.

Full Evodia guide: uses, dosage, safety and every interaction
Medication

About Larotrectinib

Brand names: Vitrakvi, VitrakviI

Vitrakvi is used to treat adults and children with solid tumors — meaning cancers in organs or tissues — that have a specific genetic change called an NTRK gene fusion. To be eligible, the tumor must be metastatic (spread to other parts of the body) or be one where surgery would likely cause serious harm, and other treatments must have stopped working or not be available.

Larotrectinib: uses, dosage and side effects Larotrectinib: interactions with other drugs Taking more than these two? Check Evodia and Larotrectinib with everything else you take Larotrectinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Evodia and Larotrectinib

Other drugs in the category this interaction applies to, and other supplements people check with Larotrectinib.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Inhibitors Category

Evodia interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

146 more in this category are on the Evodia interactions list.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Evodia interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

383 more in this category are on the Evodia interactions list.

Other Supplements With Larotrectinib

The most serious documented interactions with Larotrectinib first, then supplements with none on record, the most looked-up leading.

Show all 27 supplementsShow fewer
Keep Checking

Other Drugs & Evodia

Browse every other medication we’ve checked against Evodia — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
950Moderate
0Minor
1,879No known interaction
Moderate

Moderate: 950 interactions

Showing 60 of 950 moderate interactions — see all 950 on the Evodia page.

No Interaction 1,879 drugs checked — show the list
How Much People Look This Up

Where Evodia and Larotrectinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Evodia
Top 25%

#318 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Larotrectinib
Steady interest

#1,685 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Evodia and Larotrectinib Together: Common Questions

Can you take Evodia with Larotrectinib?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Evodia with Vitrakvi?
Vitrakvi is a brand name of larotrectinib, and so is VitrakviI, so the answer is the same as for larotrectinib. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Vitrakvi too.
Why are there 2 interaction records for Evodia and Larotrectinib?
We file interactions under single medicines and under categories of medicines that share an effect. Larotrectinib is named in, or belongs to, 2 of the categories we list for Evodia, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Evodia and Larotrectinib interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Evodia and Larotrectinib?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.